RSSL’s winning entry also provided compelling evidence of its commitment to diversity, inclusion, community and the wellbeing of its staff.
“By making sure RSSL is a great place to work, we have created an environment where everyone feels empowered to thrive – and that can only lead to even better results for our clients,” added George.
Judged by an independent panel of industry experts, the OBN Awards celebrates the most inspiring and innovative UK-based companies across biotech, medtech, imaging, digital and synthetic biology. Announcing the winners at the annual awards evening, Stuart Rose, CEO of OBN, praised the “extremely high” quality of the record-breaking number of entries and congratulated the industry for its ability to shine in the face of “some tough headwinds.”
RSSL works hand in hand with clients in the life sciences and healthcare sectors to scope, develop and manufacturer innovative drug products. It offers a diverse range of biological, microbiological, chemical and physical analytical services across all phases of clinical development through to commercial release, as well as bespoke training and consultancy. Please visit www.rssl.com to find out more.
For further press information, please contact Rachel Horton, marketing manager at RSSL: